Brief: Double Bond Pharmaceutical expands cooperation with Alexandrov Cancer Centre
15/02/2017 14:37
Feb 15 (Reuters) - Double Bond Pharmaceutical International
AB (publ) DBPHAb.ST :
* Expands the cooperation with N. N. Alexandrov Cancer
Centre of Belarus to identify biomarkers for Temodex
Source text: http://bit.ly/2lP7tC9
Further company coverage: DBPHAb.ST
(Gdynia Newsroom)
((Gdynia.newsroom@thomsonreuters.com; +48 58 772 0920;))
Recent news on Double Bond Pharmaceutical International AB (publ)
See all newsBrief: DBP International AB And Vivo Biopharma LLC Revised Asset Purchase And Collaboration Agreements
Brief: DBP International AB And Vivo Biopharma LLC Enter Into Asset Purchase And Collaboration Agreements To Develop And Commercialize A Novel Glioblastoma Treatment
Brief: DBP And Vivo Enter Into Asset Purchase And Collaboration Agreements To Develop And Commercialize A Novel Glioblastoma Treatment
Brief: Double Bond Pharmaceutical Says Positive Response For SI-053 From Ethical Committee In Netherlands Has Been Received
Brief: Double Bond To Cooperate With Belarus State Medical University